6 completed. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
Follow etamicastat: new trials by email Literature Review of etamicastat trials Research Report on etamicastat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Absorption, Distribution, Metabolism and Excretion of [14C]- Labeled BIA 5-453 and Metabolites BIA-5-453 - Hypertension, Congestive Heart Failure | Phase 1 | Completed | Bial - Portela C S.A. | 4 | 2008-09-01 | 2017-01-09 |
| Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Dose Regimens of BIA 5-453 Placebo, BIA 5-453 - Hypertension | Phase 1 | Completed | Bial - Portela C S.A. | 23 | 2008-07-15 | 2017-04-04 |
| Bioavailability Study of BIA 5-453 BIA 5-453 - Hypertension, Congestive Heart Failure | Phase 1 | Completed | Bial - Portela C S.A. | 12 | 2008-07-15 | 2017-03-27 |
| Pharmacokinetics of BIA 5-453 and Its Metabolites BIA 5-453 - Hypertension, Chronic Heart Failure | Phase 1 | Completed | Bial - Portela C S.A. | 25 | 2008-06-13 | 2017-03-27 |
| Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453 BIA 5-453, Placebo - Hypertension, Chronic Heart Failure | Phase 1 | Completed | Bial - Portela C S.A. | 57 | 2007-09-01 | 2016-07-21 |
| Tolerability, Pharmacokinetics and Dopamine ß-hydroxylase (DßH) Inhibition Profile of BIA 5-453 BIA 5-453, Placebo - Hypertension, Chronic Heart Failure | Phase 1 | Completed | Bial - Portela C S.A. | 80 | 2007-05-01 | 2016-07-26 |
Hypertension (6) · Heart Failure (2)
France (4) · Switzerland (1)